For example, inhibiting NSUN2 in PDAC reduces stromal fibrosis and restores ductal epithelial differentiation, thus slowing tumor progression and reinforcing NSUN2’s potential as a therapeutic target (Chen et al., 2022). Here, NSUN2 is linked to neoplasm.